Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial

  1. Monk, B.J.
  2. Barretina-Ginesta, M.P.
  3. Pothuri, B.
  4. Vergote, I.
  5. Graybill, W.
  6. Mirza, M.R.
  7. McCormick, C.C.
  8. Lorusso, D.
  9. Moore, R.G.
  10. Freyer, G.
  11. O'Cearbhaill, R.E.
  12. Heitz, F.
  13. O'Malley, D.M.
  14. Redondo, A.
  15. Shahin, M.S.
  16. Vulsteke, C.
  17. Bradley, W.H.
  18. Haslund, C.A.
  19. Chase, D.M.
  20. Pisano, C.
  21. Holman, L.L.
  22. Pérez, M.J.R.
  23. DiSilvestro, P.
  24. Gaba, L.
  25. Herzog, T.J.
  26. Bruchim, I.
  27. Compton, N.
  28. Shtessel, L.
  29. Malinowska, I.A.
  30. González-Martín, A.
  31. Mostra tots els autors/es +
Revista:
Annals of Oncology

ISSN: 1569-8041,  0923-7534

Any de publicació: 2024

Tipus: Article

DOI: 10.1016/J.ANNONC.2024.08.2241 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus